ArticleeLife2022

Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes.

Jingsong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.